Surface of detonation nanodiamonds was functionalized for the covalent attachment of immunoglobulin, and simultaneously bovine serum albumin and Rabbit Anti-Mouse Antibody. The nanodiamond-IgG(I125) and RAM-nanodiamond-BSA(I125) complexes are stable in blood serum and the immobilized proteins retain their biological activity. It was shown that the RAM-nanodiamond-BSA(I125) complex is able to bind to the target antigen immobilized on the Sepharose 6B matrix through antibody-antigen interaction. The idea can be extended to use nanodiamonds as carriers for delivery of bioactive substances (i.e., drugs) to various targets in vivo.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894223 | PMC |
| http://dx.doi.org/10.1007/s11671-010-9526-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Functionalization of Nanodiamond Surfaces with Metal β-Diketonato Complexes with Possible Application in Cancer Treatment.
ACS Omega
November 2024
Department of Chemistry, University of the Free State, PO Box 339, Bloemfontein 9300, South Africa.
Nanodiamonds (NDs) are used more frequently as drug carriers through absorption or chemical modification. In this report, we describe the chemical binding of metal β-diketonato complexes onto the ND surface using an aminosilane linker. The metals used were iron(III) and copper(II), with β-diketones, acetylacetone, trifluoroacetylacetone, and the naturally occurring curcumin, which is known for its biological activity.
View Article and Find Full Text PDFNanodiamonds and natural deep eutectic solvents as potential carriers for lipase.
Int J Biol Macromol
June 2024
Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
This study investigates the use of nanodiamonds (ND) as a promising carrier for enzyme immobilization and compares the effectiveness of immobilized and native enzymes. Three different enzyme types were tested, of which Rhizopus niveus lipase (RNL) exhibited the highest relative activity, up to 350 %. Under optimized conditions (1 h, pH 7.
View Article and Find Full Text PDFTargeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
Oncol Res
April 2024
Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India.
Background: Glioblastoma multiforme (GBM) is recognized as the most lethal and most highly invasive tumor. The high likelihood of treatment failure arises from the presence of the blood-brain barrier (BBB) and stem cells around GBM, which avert the entry of chemotherapeutic drugs into the tumor mass.
Objective: Recently, several researchers have designed novel nanocarrier systems like liposomes, dendrimers, metallic nanoparticles, nanodiamonds, and nanorobot approaches, allowing drugs to infiltrate the BBB more efficiently, opening up innovative avenues to prevail over therapy problems and radiation therapy.
Light-Activated Nanodiamond-Based Drug Delivery Systems for Spatiotemporal Release of Antisense Oligonucleotides.
Bioconjug Chem
May 2024
Department of Chemistry and State Key Laboratory of Marine Pollution, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Kowloon, Hong Kong SAR, China.
Nanodiamonds (NDs) are considered promising delivery platforms, but inaccurate and uncontrolled release of drugs at target sites is the biggest challenge of NDs in precision medicine. This study presents the development of phototriggerable ND-based drug delivery systems, utilizing -nitrobenzyl (-NB) molecules as photocleavable linkers between drugs and nanocarriers. UV irradiation specifically cleaved -NB molecules and then was followed by releasing antisense oligonucleotides from ND-based carriers in both buffer and cellular environments.
View Article and Find Full Text PDFNanodiamond-based berberine aquasomes for enhancing penetration across epidermis to treat psoriasis.
Int J Pharm
May 2024
Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, V. L. Mehta Road, Vile Parle (W), Mumbai, India. Electronic address:
The use of berberine hydrochloride (BCS class III) has limited application in psoriasis, when given as topical drug delivery systems, due to low permeability in the skin layer. Hence, berberine hydrochloride-loaded aquasome nanocarriers were developed for skin targeting, particularly epidermis (primary site of psoriasis pathophysiology) and enhance the skin permeability of berberine hydrochloride. Aquasomes were formulated using the adsorption method and characterized by structural morphology TEM, % drug adsorption, drug release profile (in-vitro and ex-vivo), in-vivo efficacy study and stability study.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!